Search results
Results from the WOW.Com Content Network
Throughout its history, IMS Health's business of collecting anonymized pharmaceutical sales data came under scrutiny from both the media and the legal system. [27] IMS Health v. Ayotte was a free speech case involving IMS Health. [28] [29] [30] Sorrell v.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The Vifor Pharma Group's net sales grew by 2.8% during the year, with the gross profit margin improving to 63.2%. Vifor Pharma AG (SWX:VIFN.SW)'s latest market capitalization is $11.6 billion.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
2018 sales (million USD) 2017 sales (million USD) 1 adalimumab: rheumatoid arthritis: Humira 19 936 18427 3 apixaban: anticoagulant: Eliquis 9872 7395 4 lenalidomide: multiple myeloma: Revlimid 9685 8187 5 nivolumab: oncology: Opdivo 7570 5763 6 pembrolizumab: oncology: Keytruda 7171 3809 7 etanercept: rheumatoid arthritis: Enbrel 7126 7885 8 ...
The bust was the “largest ever criminal enforcement action targeting distributors of pharmaceutical opioids and commonly abused prescription drugs with estimated street value of $1.3 billion ...
Ista Pharmaceutical: $14.6 $11.3 $8.3 $2.6 bromfenac: Xibrom Ocular inflammation Ista Pharmaceutical: $63 $42.1 $20.2 $5.3 hyaluronidase: Vitrase Spreading agent Ista Pharmaceutica: $5.2 $5.2 $4.2 $2.5 rivaroxaban: Xarelto Deep vein thrombosis Johnson & Johnson [39] $1,868 $1,522 $864 $239 $25